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INTRODUCTION 
Intervention with variety of pharmacological agents especially during sensitive period of the 
developing Central Nervous System (CNS) has been shown to result in potentially long lasting 
neurobehavioural and/or neurochemical abnormalities [1]. The leaves of MS, (family: Rubiaeae), 
locally named katum or kratom is a plant endemic to tropical Southeast Asia, used by natives for 
opium-like effects and stimulant ability to combat fatigue and enhance tolerance to hard work [2]. Its 
recreational use has been banned in many countries including Australia, Burma, Thialand and 
Malaysia, due to concerns over dependence liability potential. MS contains many alkaloids including 
mitragynine (once thought to be the primary active), mitraphylline, and 7-hydroxymitragynine (which 
is currently the most likely candidate for the primary active chemical in the plant). Although 
structurally related to yohimbine and other tryptamines, its pharmacology is quite different, acting 
primarily as a mu-opioid receptor agonist. It also shares some adrenergic receptor activity similar to 
that of yohimbine. MS also contains alkaloids found in uña de gato, which are thought to play a 
beneficial role on the immune system and lower blood pressure, as well as epicatechin, a powerful 
antioxidant also found in dark chocolate and closely related to the EGCG that gives green tea its 
beneficial effects. Other active chemicals in MS include raubasine (best known from Rauwolfia 
serpentina) and some yohimbe alkaloids such as corynantheidine [3]. The opioid-like effects, of MS 
alkaloids, the naloxone-induced withdrawal syndrome and cross tolerance with morphine [2,4,5], all 
point to a dependence liability potential.  These findings also raise questions on the possibilities and 
potentials that these alkaloids have to other toxicological effects and mechanisms. The vulnerability 
of the developing central nervous system to a variety of neuroactive substances is well documented. 
ABSTRACT 
The developmental effects of in-utero administration of the crude ethanolic extract of the leaves of 
Mitragyna speciosa (MS) on neural tube in fetal rats were investigated. Pregnant Sprague-Dawley rats were 
dosed orally once daily by gavage, with graded (500, 1000 and 1500 mg/kg) doses of the extract between the 
8th and 13
th
 day prenatally. The control group received corn oil used as vehicle for the extract. On the 18th 
day of gestation, mothers were sacrificed and embryos removed and stained under established procedures. 
The embryos were then analyzed for the presence of neural tube defects (NTD) through measurements of the 
extent of vertebral arch closure and brain size. Results indicate that the medium (C) and high (D) (1000 & 
1500mg/kg) doses but not the low (B) (500mg/kg) dose in comparison with control (A) group, significantly 
(p≤0.001) produced a widening of the vertebral arch in the thoracic, lumber and cervical regions of the 
spinal cord. The brain transverse diameter was also significantly (p≤0.05) increased by the high dose only. 
These effects were seen in the absence of any significant differences in litter size and other gross physical 
abnormalities. This study indicates that the crude extract of the leaves of MS is capable of selective 
neurotoxicity and producing spina bifida like NTD as characterized by altered brain size and neural tube 
formation, a finding that may have an important implication in the dependence liability associated with its 
use.  
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The “brain growth spurt”, a period of heightened neuronal development which in the rat is around day 
10 prenatally, is especially sensitive to the toxic effects of many neuroactive agents. In this study, we 
investigate the effect of in utero administration of the crude ethanolic extract of the leaves of MS on 
neural tube development of fetal rat. 
 
MATERIALS AND METHODS 
Preparation of plant extracts: Authenticated plant material (leaves of MS) was air-dried at room 
temperature under shade and grinded into powdered form. Two kilograms material was extracted in 
soxhlet extractor three times (in order to ensure maximum yield) for about 2 h every time with 90% 
ethanol (EtOH). The extract was meticulously filtered and solvent evaporated to dryness under 
reduced pressure below 50°C to yield a purified EtOH extract. Dry extract were stored in a deep 
freezer at –30°C until reconstituted for use.. 
LD50 (Safety profile): Oral acute lethal dose study was carried out (to determine the safety profile) 
using the revised Up and Down (UPD) procedure according to recommendations [6,7]. 
Animal dosing: Pregnant prague-Dawley rats (weighing 156-246g each) were randomly assigned 
groups, caged individually and were fed rat chow and water ad libitum under 12:12 light: dark cycle. 
The rats were dosed orally by gavage between day 8 and 13 of gestation with corn oil (control) or 
graded doses (500, 1000 and 1500 mg/kg) of the crude extract of MS. 
Sample processing and staining: At 18 days gestation the females were euthanized with chloroform, 
the abdomen opened through laparotomy and the uterus and uterine contents removed. Fetuses were 
“milked out” and their abdomens opened to allow adequate penetration of 10% formalin in which they 
were immersed. Fetuses were stained for bone and cartilages after 4 days of fixation as described 
previously [8]. Briefly, the fetuses were eviscerated and skinned. Cartilage was stained with Alcian 
blue followed by bone staining with alizarin red. The fetuses were then cleared in KOH and graded 
concentrations of glycerol [8].  
Measurement of vertebral canal diameter: After clearing the fetuses were inspected with a 
dissecting microscope and the width of the vertebral arch gap was measured with computer built-in 
micrometer gauge, from T-9 to S-4 [8].  
Measurement of the brain diameter: After fixation of the fetuses the brain was dissected out of the 
head through the use of knife and dissecting forceps. The brains were weighted and processed for 
histology preparation. Briefly the fetal brains were processed over 24 hours in a manual tissue 
processing system that includes graded ethanol, xylene and paraffin. The brains were embedded and 
sectioned and then stained with haematoxilin and eosin. 
Measurement of the width of gray and white matter was carried out. This is to correlate with the width 
of the mantle and marginal layers.      
Data analysis: Data was analyzed using one-way ANOVA and a Bonferonni post-hoc test for 
comparison between groups, with SPSS version 12.0. Values are expressed as mean ± sem. 
Significant differences was considered when P ≤ 0.05. 
 
RESULTS 
LD50 (Safety profile): None of the 5 rats died nor showed any sign of toxicity at the limit dose of 
3000mg/kg/oral OD per rat, and no evidence of toxicity was noted during 5 days of observation. The 
LD50 of MS in rats was therefore taken as above 3000 mg/kg/oral. Graded doses (500, 1000 and 
1500mg/kg) of the crude extract of MS were chosen to study the effect of in utero administration on 
neural tube development in fetal rats. 
Measurement of neural tube diameter: Neural tube diameter of fetuses treated in utero with graded 
doses of MS, indicates that the medium (C) and high (D) (1000 & 1500mg/kg) doses but not the low 
(B) (500mg/kg) dose in comparison with control (A) group, significantly (p≤001) produced a 
widening of the vertebral arch in the thoracic, lumber and cervical vertebral regions of spinal cord 
(fig.1).  
Measurement of the brain diameter: Brain diameter was significantly (p≤001) increased 
transversely (table 1) in the high dose treatment group in comparison with the control.  
Other abnormalities: There were no other gross physical abnormalities any significant differences in 
litter size observed in the rat pups.  The mean daily weight changes of pregnant rats over the treatment 
period, day 8- 13 of gestation was also not significantly different between treatment groups (fig 2). 
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However, the mean litter weight of the low dose (500mg) was significantly lower, while that of 
medium dose (1000mg/kg) group was significantly higher than the control group (table 2). 
Table 1: The effect of maternal treatment of crude ethanolic extract of Mitragyna speciosa on Brain 
Size Measurement in Fetal Rats. 
Treatment Group AnteriorPosterior 
Diameter (µm) ± sem 
Transverse  
Diameter (µm)  ± sem 
Control  5924.6 ± 832 3642.7 ± 253 
M. speciosa 
500mg/kg/day 
6212.1 ± 769 4895.7 ± 452  
M. speciosa 
1000mg/kg/day 
4491.2 ± 655 3464.9 ± 476 
M. speciosa 
1500mg/kg/day 
8750.6 ± 800 7244.1 ± 696** 
** = P≤0.001 
  
Table 2: The effect of maternal treatment of crude ethanolic extract of Mitragyna speciosa on Litter 
weight and size of fetal rats. 
Treatment Group 
 
Mean litter 
weight (g) ± sem 
 
Mean litter  
Size ± sem 
 
Number of fetal 
rats (n) 
 
Control 1.49 ± 0.09 9.75 ± 1.3 39 
M. speciosa  
500mg/kg/day 
1.27 ± 0.9* 10.60 ± 1.7 53 
M. speciosa  
1000mg/kg/day 
2.04 ± 0.05** 8.00 ± 1.0 24 
M. speciosa 
1500mg/kg/day 
1.45 ± 0.59 7.50 ± 1.5 45 
* =P ≤ 0.05; ** = P ≤ 0.001 
 
DISCUSSION  
Our studies have shown that the crude ethanolic extract of the leaves of Mitragyna speciosa (MS) is 
capable of altering neural tube formation and causing a Spina Bifida-like neural tube defects, 
characterized by failure of neural tube of the developing fetus to close properly [8]. There were no 
observable physical abnormalities or effect on litter size although a reduction and corresponding 
increase in litter weight was seen in the low and medium dose groups respectively. Effect on litter 
weight after chronic MS in utero has been reported previously [9]. Considerable amount of literature 
from human and animal studies exist showing a greater vulnerability of the developing nervous 
system particularly during critical period, to a variety of environmental toxicants and neuroactive 
agents. Such exposure if coincident with neural developmental processes including proliferation, 
migration, differenciation, synaptogenesis, myelination and apoptosis, may cause enduring functional 
and behavioural abnomalities in the offspring later in life [1]. Pharmacological but not structural 
association has been made between morphine, a prototype opioid agonist and the alkaloids of MS. 
Further, the development of tolerance and cross-tolerance as well as mu-opioid receptor selectivity of 
morphine and MS [10,2], may suggest commonality in the biochemical and molecular mechanisms of 
opioid-induced dependence effects. The report of Fazel & Jalali [11] demonstrating a high incidence 
of CNS defects including exencephaly and spina bifida in fetal mice exposed in utero to morphine on 
days 10 and 11 of gestation, period that are critical in CNS development, is an attraction to our study. 
Indeed, CNS disorders including some seemingly peripheral diseases, like chronic pain and disorders 
in major organs have clear pathological basis in the CNS. Pathological insults and long-term plastic 
changes within neural circuits may lead to maladaptive behaviours. Drug addiction is a chronic brain 
disease characterized by compulsive drug-seeking, craving and taking behaviour. Experimental 
evidence suggests that following exposure to drugs of abuse, neurones within the mesolimbic 
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dopamine system undergo a series of plastic changes that may lead to compulsive emotional and  
motivational  states [12].      In support of this, Antony et al., [13] have demonstrated an association   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Effect of crude ethanolic extract of Mitragyna speciosa on neural tube diameter of fetal rats. 
Histogram represent mean ± sem (24-53 pups per treatment group) neural tube diameter of fetal rats 
of control and Mitragyna speciosa (graded doses) treated mothers.  * =P ≤ 0.05; ** = P ≤ 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Percentage weight difference (Stem-and-Leaf Plots) of control and Mitragyna speciosa 
treated Pregnant Rats, (n = 4-6). No significant difference between control and Mitragyna speciosa 
treated groups. 
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between risk of alcoholism and developmental defects of specific brain structures, in which children 
having strong family loading for alcoholism were found more vulnerable to developing alcoholism 
than those having no history of alcohol dependence. These subjects were shown to have significantly 
lower volumes of certain brain structures such as the left and right amygdala and hippocampus (due to 
dysregulation of brain reward system), areas implicated in the aetiology of drug and alcohol addiction 
[14].  
 
CONCLUSION 
In conclusion, the Spina bifida-like NTD induced by MS may bring about structural alterations in the 
course of neuronal developmental processes including alterations in biochemical and receptor 
mechanisms important in the genesis of opioid-induced dependency. Further studies will however be 
needed to determine possible association between these structural and behavioural alterations and 
vulnerability to opioid dependence liability potential.   
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